Literature DB >> 20419423

Studying endoplasmic reticulum function in vitro using siRNA.

Cornelia M Wilson1, Stephen High.   

Abstract

In eukaryotic cells, N-glycosylation is typically the most common protein modification that occurs in the endoplasmic reticulum (ER) lumen. N-glycosylation is facilitated by a large heterologous protein complex called the oligosaccharyltransferase (OST) that allows the attachment of a high mannose oligosaccharide from a dolichol pyrophosphate donor en bloc onto suitable asparagine residues of newly synthesized nascent chains during translocation into the ER lumen (1). While the complexity of the OST is highly conserved in eukaryotes, the role of its different subunits is poorly defined. We have investigated the function of three OST subunits, the ER translocon-associated component ribophorin I, and two isoforms of the presumptive catalytic subunit, STT3. We use a combination of siRNA-mediated knockdown of individual proteins combined with a semi-permeabilized mammalian cell system to provide a robust read out for OST subunit function during N-glycosylation of model substrates in vitro. This approach is equally applicable to the study of other cellular components.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20419423     DOI: 10.1007/978-1-60327-412-8_23

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  DC2 and keratinocyte-associated protein 2 (KCP2), subunits of the oligosaccharyltransferase complex, are regulators of the gamma-secretase-directed processing of amyloid precursor protein (APP).

Authors:  Cornelia M Wilson; Amandine Magnaudeix; Catherine Yardin; Faraj Terro
Journal:  J Biol Chem       Date:  2011-07-18       Impact factor: 5.157

2.  Endoplasmic reticulum stress-induced apoptotic pathway and mitochondrial dysregulation in HeLa cells treated with dichloromethane extract of Dillenia suffruticosa.

Authors:  Wan Abd Ghani Wan Nor Hafiza; Latifah Saiful Yazan; Yin Sim Tor; Jhi Biau Foo; Nurdin Armania; Heshu Sulaiman Rahman
Journal:  Pharmacogn Mag       Date:  2016-02-10       Impact factor: 1.085

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.